QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, July 2, 2003, 23(13):5835-5845

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (38) Citing Articles via Google Scholar Google Scholar Articles by Mosharov, E. V. Articles by Lindau, M. Search for Related Content PubMed PubMed Citation Articles by Mosharov, E. V. Articles by Lindau, M.

 Previous Article  |  Next Article 

Cellular/Molecular
Intracellular Patch Electrochemistry: Regulation of Cytosolic Catecholamines in Chromaffin Cells

Eugene V. Mosharov,¹ Liang-Wei Gong,² Bhavanna Khanna,² David Sulzer,¹ and Manfred Lindau²

¹Departments of Neurology and Psychiatry, Columbia University, New York, New York 10032, Department of Neuroscience, New York State Psychiatric Institute, New York, New York 10032, and ²School of Applied and Engineering Physics, Cornell University, Ithaca, New York 14853

Alterations in the cytosolic pool directly affect neurotransmitter synthesis and release and are suggested to be key factors in various neurodegenerative disorders. Although this cytosolic pool is the most metabolically active, it is miniscule compared with the amount of vesicular transmitter and has never been quantified separately. Here, we introduce intracellular patch electrochemistry (IPE), a technique that for the first time provides direct measurements of cytosolic oxidizable molecules in single mammalian cells. In amperometric mode, IPE detects total catechols, whereas in cyclic voltammetric mode, it preferentially measures catecholamines. In cultured chromaffin cells, the total cytosolic catechol concentration was 50–500 µM, of which 10% were catecholamines. Reserpine, a vesicular monoamine transporter inhibitor, had no effect on the catecholamine pool but increased total catechols by fourfold to fivefold. Combined with pargyline, a monoamine oxidase inhibitor, reserpine increased catecholamine levels in the cytosol by approximately sixfold. Amphetamine induced a transient approximately fivefold accumulation of cytosolic catecholamines and a slow increase of total catechols. In cells incubated with 3,4-dihydroxy-L-phenylalanine (L-DOPA), catecholamines increased by 2.5-fold and total catechols increased by approximately fourfold. Cytosolic catecholamines returned to control levels 10 min after L-DOPA withdrawal, whereas total catechols remained approximately twofold elevated even after a 1.5 hr incubation in L-DOPA-free media. Our data indicate that cytosolic catecholamines are strictly maintained at a defined level, and drug-induced increases in their concentrations lead to the accumulation of other catecholamine derivatives, such as DOPAC and 3,4-dihydroxyphenylethyleneglycol. These derivatives reside in the cytosol for hours after treatment and may be an underlying cause of drug-related cytotoxicity.

Key words: patch-amperometry; cyclic voltammetry; cytosolic catecholamine; chromaffin cells; reserpine; pargyline; amphetamine; L-DOPA

---

Received Feb 11, 2003; revised April 17, 2003; accepted April 21, 2003.

This article has been cited by other articles:

				F. Binda, C. Dipace, E. Bowton, S. D. Robertson, B. J. Lute, J. U. Fog, M. Zhang, N. Sen, R. J. Colbran, M. E. Gnegy, et al. Syntaxin 1A Interaction with the Dopamine Transporter Promotes Amphetamine-Induced Dopamine Efflux Mol. Pharmacol., October 1, 2008; 74(4): 1101 - 1108. [Abstract] [Full Text] [PDF]

				M. S. Montesinos, J. D. Machado, M. Camacho, J. Diaz, Y. G. Morales, D. Alvarez de la Rosa, E. Carmona, A. Castaneyra, O. H. Viveros, D. T. O'Connor, et al. The Crucial Role of Chromogranins in Storage and Exocytosis Revealed Using Chromaffin Cells from Chromogranin A Null Mouse J. Neurosci., March 26, 2008; 28(13): 3350 - 3358. [Abstract] [Full Text] [PDF]

				K. Nakamura and R. H. Edwards Physiology versus pathology in Parkinson's disease PNAS, July 17, 2007; 104(29): 11867 - 11868. [Full Text] [PDF]

				S. Murase and R. D. McKay A specific survival response in dopamine neurons at most risk in Parkinson's disease. J. Neurosci., September 20, 2006; 26(38): 9750 - 9760. [Abstract] [Full Text] [PDF]

				E. V. Mosharov, R. G. W. Staal, J. Bove, D. Prou, A. Hananiya, D. Markov, N. Poulsen, K. E. Larsen, C. M. H. Moore, M. D. Troyer, et al. {alpha}-Synuclein Overexpression Increases Cytosolic Catecholamine Concentration J. Neurosci., September 6, 2006; 26(36): 9304 - 9311. [Abstract] [Full Text] [PDF]

				R. M. Wightman Detection technologies. Probing cellular chemistry in biological systems with microelectrodes. Science, March 17, 2006; 311(5767): 1570 - 1574. [Abstract] [Full Text] [PDF]

				J. Xu, K. S. Tang, V. B. Lu, C. P. Weerasinghe, A. Tse, and F. W. Tse Maintenance of quantal size and immediately releasable granules in rat chromaffin cells by glucocorticoid Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1122 - C1133. [Abstract] [Full Text] [PDF]

				J. Lotharius, J. Falsig, J. van Beek, S. Payne, R. Dringen, P. Brundin, and M. Leist Progressive Degeneration of Human Mesencephalic Neuron-Derived Cells Triggered by Dopamine-Dependent Oxidative Stress Is Dependent on the Mixed-Lineage Kinase Pathway J. Neurosci., July 6, 2005; 25(27): 6329 - 6342. [Abstract] [Full Text] [PDF]

				K. M. Kahlig, F. Binda, H. Khoshbouei, R. D. Blakely, D. G. McMahon, J. A. Javitch, and A. Galli Amphetamine induces dopamine efflux through a dopamine transporter channel PNAS, March 1, 2005; 102(9): 3495 - 3500. [Abstract] [Full Text] [PDF]

				N. Kholodilov, O. Yarygina, T. F. Oo, H. Zhang, D. Sulzer, W. Dauer, and R. E. Burke Regulation of the Development of Mesencephalic Dopaminergic Systems by the Selective Expression of Glial Cell Line-Derived Neurotrophic Factor in Their Targets J. Neurosci., March 24, 2004; 24(12): 3136 - 3146. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help